Issue Date: July 5, 2010
AstraZeneca Compounds Get Malaria Screening
AstraZeneca will open its compound library to Medicines for Malaria Venture, a nonprofit group working to speed the development of new malaria treatments. MMV has enlisted Vicky Avery of Australia’s Griffith University to screen the library’s 500,000 compounds against Plasmodium falciparum, the most lethal of the malaria parasites. Any promising compounds will be funneled to AstraZeneca’s R&D facility in Bangalore, India, for further exploration. AstraZeneca appears to be upping its commitment . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society